Bloomberg Talks podcast

Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill

12/23/2025
0:00
8:09
Rewind 15 seconds
Fast Forward 15 seconds

Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

See omnystudio.com/listener for privacy information.

More episodes from "Bloomberg Talks"